Joseph Walker is a Reporter at The Wall Street Journal. He covers a range of topics including pharma, biotech, consumer health, and mental health, with a particular focus on pharmaceutical manufacturing and regulation. Joseph's work has been featured in prominent publications such as The Globe and Mail, Reuters, and Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Joseph Walker's coverage is heavily focused on the health and healthcare industries, particularly regarding pharmaceutical companies, drug approvals, regulatory actions by government agencies like the FDA, and policy developments affecting drug prices. He has a specific focus on US-based news.
If you are reaching out to Joseph with a pitch or as a potential source, ensure that your expertise aligns with these areas of interest. Topics such as FDA approval processes for new drugs, investigations into health insurers' role in driving up drug costs, and industry responses to regulatory changes could be particularly relevant based on his recent articles.
Given his high percentage of press releases cited in coverage attributes (23%), providing access to exclusive data or insider perspectives related to major announcements from pharmaceutical companies or healthcare institutions may increase the likelihood of getting noticed by Joseph.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Joseph Walker
Experience Italy First, Then Make Your Dream of Italian Homeownership a Reality
The agency’s crackdown represents a significant rise in scrutiny of pharmaceutical ads in recent years.
By: Joseph Walker, Peter Loftus
President Trumps plan for new tariffs on pharmaceuticals landed like a bomb on social media late Thursday, but many of the worlds richest drugmakers
| Small biotechs that use manufacturers overseas could be hit harder by levies - By JosepH WALKER Anp PETER Lortus
By: Joseph Walker, Peter Loftus
If you are among the 90% of Americans who have health insurance, it’s unlikely to save you much money
President Trump on Tuesday announced the first of what he says are many more deals to come with drugmakers to lower the prices they charge in the
By: Peter Loftus, Natalie Andrews, Joseph Walker
AstraZeneca is the latest major drugmaker to agree to a deal with the Trump administration on lowering the prices of its drugs, some of which will
By: Elisa R. Zanier, Stefania Mondello, Samar Abdelhady, Joseph Walker, Federico Moro, Ali Eid, Corina O. Bondi, Fatima Dakroub, Kevin K. Wang, Bassel Awada, Firas Kobeissy, Yehia Mechref, Abdullah A. Shaito
Fatima Dakroub ∙ Bassel Awada ∙ Samar Abdelhady ∙ … ∙ Elisa R. Zanier [email protected] ∙ Yehia
The Metropolitan Washington Council of Governments leads an interjurisdictional effort to display crime data and guide public safety decisions
By: Joseph Walker
Joseph Walker, Director, Chameleon Travel Shop Chameleon Travel Shop's small group Italy tours pair famous monuments with sites most travelers never find.
